That bottle of ibuprofen in your medicine cabinet is more powerful than you may think.
A new study by Harvard Medical School researchers suggests that the pain reliever may offer protection against developing Parkinson’s disease by targeting a certain receptor in the brain.
The analyzed data from more than 127,000 people who reported their use of ibuprofen and other nonsteroidal anti-inflammatory drugs over a six year period – and what they found was the participants who took ibuprofen on a regular basis had a 38 percent lower risk of developing the brain disorder.
Dr. Hubert Fernandez, a neurologist from the Cleveland Clinic, weighed in on the study.
“It's a promising drug, it's a well tolerated medication if used with caution and used correctly,” he said. “So, we might shoot two birds with one stone.”
The findings are published in the journal of the American Academy of Neurology.